Why Weight Loss Medications Alone Aren't Enough In Midlife
I see women who have been doing everything right -- eating “clean", walking and exercising, but they’re gaining weight, particularly around the belly.
This isn't just vanity. Heart disease risk increases for women at the menopausal transition, begging the question as to whether we can decrease these risks.
Body Weight & Composition Changes in Midlife
As estrogen declines, fat gets stored differently than our pre-menopausal years. Women typically store fat around the hips and suddenly it's around the belly.
Muscle mass is typically decreasing without intentional effort to curb the loss.
Insulin resistance is increasing as estrogen decreases.
Sleep is often suffering, disrupting hormones that lead to more eating, more storage and more stress.
You’re doing the same things, but suddenly this body looks and feels foreign. There's a new hormonal environment.
What Weight Loss Medications Do Well
GLP1 agonist medications (weight loss medications) are effective at inducing weight loss. They do this by suppressing appetite. They keep you from overriding by deciding to eat because you're hungry (or bored, stressed, craving, or any other reasons that cause us to eat more). With that comes improved insulin sensitivity and heart risk markers.
What they don't do is replace hormones that have declined.
These hormonal changes in midlife are causing decreased muscle mass, increased fatigue, and maybe plateau of weight loss.
What HRT (and a thoughtful plan) Can Do
Restoring the favorable hormonal environment is what HRT does best.
This could be a combination of estrogen + progesterone + testosterone depending on your plan. (I personally don't start all medications at once to avoid confusing results and side effects).
Sleep likely improves, with exercise the body composition and maintenance of muscle mass can improve, and insulin sensitivity improves (thank you, estrogen).
Why They Work Better Together
Hormonal environment + metabolic improvement = best results.
This isn't just my opinion. This is now being fleshed out in scientific studies.
One study looked at women taking semaglutide (Ozempic, Wegovy). Some were also taking HRT and some were not. In the group taking HRT + semaglutide, weight loss was higher.
Another study was similar but looked at tirzapetide (Zepbound, Mounjaro), with and without HRT. Women taking HRT + tirzapetide had improved weight loss and heart risk markers. More women were able to achieve 20% body weight loss when using GLP + HRT together.
Why Most Women Aren't Offered Both
At least not in the same place. This is fragmented care. Women are treated as pieces, not as a whole.
Finding weight loss medications can feel like the Wild West. Weight loss clinics may do part of it, hormone clinics may do another.
Traditional medicine has limited knowledge and experience treating midlife women and visits too short to individualize care on this level.
Hormone clinics are often subscription and protocol-based.
A Better Approach
GLP and HRT medications require individualized care, personalized hormone and risk evaluation.
Both require thoughtful titration, monitoring, and willingness to change course.
Lifestyle isn’t optional. Maintaining muscle mass requires strength training, heart health requires movement that increases the heart rate.
If you're tired of guessing, Googling, or being told everything is normal, you're in the right place. This is exactly why I created my telehealth practice.
Your body isn't failing. It needs a different kind of care.
On a GLP and noticing your hair falling out? Find doctor-recommended hair support here.
Resources:
Some of the information contained in this article is the result of my training, medical knowledge, and personal experience without a specific source to be cited.
The author can earn commissions through affiliate links.
Disclaimer: This is not medical advice. This is for educational purposes only. Discuss with your doctor.
Hurtado MD, Tama E, Fansa S, Ghusn W, Anazco D, Acosta A, Faubion SS, Shufelt CL. Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use. Menopause. 2024 Apr 1;31(4):266-274. doi: 10.1097/GME.0000000000002310. Epub 2024 Mar 5. PMID: 38446869; PMCID: PMC11209769.
Castaneda R, Bechenati D, Tama E et al.
The role of menopause hormone therapy in modulating tirzepatide-associated weight loss in postmenopausal women with overweight or obesity: a retrospective cohort study
The Lancet Obstetrics, Gynaecology, & Women’s Health, 2026; 2, e118-e128
